Genomadix articles

TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). Genomadix’s FDA-cleared rapid RX CYP2C19 genotyping test was used to personalize antiplatelet therapy with clopidogrel or ticagrelor. The results were published on August 25, 2020 in the Journal of the American Medical Association (JAMA). The results showed that:
• Genotype-guided therapy resulted in 34% fewer

If you’re reading this post, you’ve likely decided that testing for Legionella in your building is important for protecting your occupants. If you’re not aware of the dangers of Legionella bacteria, our recent blog post can give you an idea of why you should protect your building from Legionella and why buildings that have been shut down due to COVID-19 are at higher risk of contamination.

How often should water systems be tested for Legionella?

Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results
*The largest genetics-based clinical trial in cardiology history supported by Genomadix’s Precision Medicine technology *

The results of the TAILOR-PCI trial (Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response after Percutaneous Coronary Intervention) were recently announced at the ACC virtual event. This seven-year-long trial was suppo

After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. This is based on the well-established evidence that approximately 30-50% of patients carry loss-of-function mutations for the CYP2C19 enzyme responsible for Clopidogrel bioactivati

The CDC chose Genomadix Bioscience, an Ottawa-based biotechnology company, to assist with a Legionnaires’ outbreak in Chesterfield, VA.

The Virginia Department of Health (VDH) identified an increase in Legionnaires’ disease cases in Chesterfield County and requested assistance from the Centers for Disease Control and Prevention (CDC). During the investigation, the CDC Pneumonia Response Laboratory used Genomadix’s on-site Legionella qPCR test and found Legionella bac